Saturday, December 14, 2019

 


Hexo Corp
(TSX: HEXO.TO) Add to Watchlist
$2.95
+0.02 (+0.68%)
as of Dec 13, 2019

Last 2.95
Change +0.02 (+0.68%)
Open 2.96
Prev. Close 2.93
Today's Range
2.87 3.03
52wk Range
2.06 11.29
Volume 2,808,912
Avg Volume 3,303,497

Recent Headlines
For the second year, the U.S. FDA designated psilocybin, a compound found in hallucinogenic mushrooms, as a "breakthrough therapy" for the treatment of major depressive disorder (MDD). "This designation, which is designed to expedite the development and review of drugs--given out only for therapies  (full story)
BOSS.CN: 0.230 (-0.010), BOSQF: 0.1771 (-0.0029), HEXO: 2.24 (+0.01), HEXO.TO: 2.95 (+0.02), TRUL.CN: 15.920 (-0.020), TCNNF: 12.0900 (+0.0328), TGOD.TO: 0.83 (+0.01)
Many more Americans now support cannabis legalization. A Pew Research Center survey now finds that 67% are in support. That's up from 62% year. Better, the House Judiciary Committee just passed The Marijuana Opportunity Reinvestment and Expungement (MORE) Act with a vote of 24 to 10. While the bill  (full story)
EAT.CN: 0.045 (unch), SPLIF: 0.0284 (-0.0036), APHA: 5.50 (+0.23), APHA.TO: 7.26 (+0.32), TLRY: 18.60 (-0.33), HEXO: 2.24 (+0.01)
TORONTO — Some of the most active companies traded Thursday on the Toronto Stock Exchange:  (full story)
ZENA.TO: 0.20 (unch), ACB.TO: 3.47 (+0.03), HRT.TO: 0.13 (unch), TV.TO: 0.21 (+0.01), HEXO.TO: 2.95 (+0.02), WEED.TO: 27.28 (-0.57), BCE.TO: 62.69 (-1.52)
Performance Comparison
Name Today 3-Month 1-Year
HEXO.TO +0.68% -44.02% -40.88%
$TXCX +0.33% +3.87% +15.27%
$TXCI +0.25% +3.82% +14.56%
DJIA +0.01% +7.38% +14.38%
S&P 500 +0.01% +8.87% +19.55%

Key Statistics
Annual EPS -0.38
Dividend & Yield -- (--)
P/E Ratio N/A
Market Capitalization, $K 758,205
Weighted Alpha -38.00
Standard Deviation +0.07
Profit Margin -1.72%
Beta 5.01

Growth Rates
YTD -37.37%
1-Year -40.40%
3-Year +337.04%
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.